264 related articles for article (PubMed ID: 25933967)
61. Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration.
Zimmermann ES; Laureano JV; Dos Santos CN; Schmidt S; Lagishetty CV; de Castro WV; Dalla Costa T
Antimicrob Agents Chemother; 2016 Feb; 60(2):946-54. PubMed ID: 26621623
[TBL] [Abstract][Full Text] [Related]
62. Midazolam as a phenotyping probe to predict sunitinib exposure in patients with cancer.
de Wit D; Gelderblom H; Sparreboom A; den Hartigh J; den Hollander M; König-Quartel JM; Hessing T; Guchelaar HJ; van Erp NP
Cancer Chemother Pharmacol; 2014 Jan; 73(1):87-96. PubMed ID: 24149944
[TBL] [Abstract][Full Text] [Related]
63. Determination of sunitinib and its active metabolite N-desethylsunitinib in sweat of a patient.
Lankheet NA; Blank CU; Mallo H; Adriaansz S; Rosing H; Schellens JH; Huitema AD; Beijnen JH
J Anal Toxicol; 2011 Oct; 35(8):558-65. PubMed ID: 22004675
[TBL] [Abstract][Full Text] [Related]
64. Pharmacokinetics of intravenous and oral levofloxacin in critically ill adults in a medical intensive care unit.
Rebuck JA; Fish DN; Abraham E
Pharmacotherapy; 2002 Oct; 22(10):1216-25. PubMed ID: 12389872
[TBL] [Abstract][Full Text] [Related]
65. Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of sunitinib (SU11248) and its active metabolite, N-desethyl sunitinib (SU12662), in human plasma: application to an explorative study.
Rodamer M; Elsinghorst PW; Kinzig M; Gütschow M; Sörgel F
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):695-706. PubMed ID: 21367676
[TBL] [Abstract][Full Text] [Related]
66. Development of a novel conjugatable sunitinib analogue validated through in vitro and in vivo preclinical settings.
El Mubarak MA; Leontari I; Efstathia G; Vrettos EI; Shaikh AK; Konstantinos SE; Danika C; Kalofonos HP; Tzakos AG; Sivolapenko GB
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():515-523. PubMed ID: 30008308
[TBL] [Abstract][Full Text] [Related]
67. Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib.
Beuselinck B; Lambrechts D; Van Brussel T; Wolter P; Cardinaels N; Joniau S; Lerut E; Karadimou A; Couchy G; Sebe P; Ravaud A; Zerbib M; Caty A; Paridaens R; Schöffski P; Verkarre V; Berger J; Patard JJ; Zucman-Rossi J; Oudard S
Acta Oncol; 2014 Oct; 53(10):1413-22. PubMed ID: 24874929
[TBL] [Abstract][Full Text] [Related]
68. Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure.
George S; Blay JY; Casali PG; Le Cesne A; Stephenson P; Deprimo SE; Harmon CS; Law CN; Morgan JA; Ray-Coquard I; Tassell V; Cohen DP; Demetri GD
Eur J Cancer; 2009 Jul; 45(11):1959-68. PubMed ID: 19282169
[TBL] [Abstract][Full Text] [Related]
69. [Study of pharmacokinetics/pharmacodynamics of levofloxacin].
Zhang J; Yu JC; Shi YG; Zhou L; Ye XY; Zhu DM; Zhang YY
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1926-32. PubMed ID: 16255991
[TBL] [Abstract][Full Text] [Related]
70. Population pharmacokinetics of intravenous levofloxacin 500 mg/day dosage in infected patients.
Zhang Y; Zhu LQ; Wang N; Zhao X; Yang W; Ji S; Sun L
Pharmazie; 2014 Jul; 69(7):553-7. PubMed ID: 25073403
[TBL] [Abstract][Full Text] [Related]
71. Suicide attempt with an overdose of sunitinib.
Arai S; Matsui H; Ohki R; Miyazawa Y; Koike H; Hashita T; Katsuyama Y; Sekine Y; Nomura M; Shibata Y; Hatori M; Ito K; Yamamoto K; Ohmori S; Suzuki K
Br J Clin Pharmacol; 2014 Oct; 78(4):933-5. PubMed ID: 24645902
[No Abstract] [Full Text] [Related]
72. [Experimental comparative pharmacokinetics of levofloxacin, triazavirin, and related conjugate].
Blazhennikova IV; Kurliakova AF; Bykov VN; Geĭbo DS; Nikiforov AS; Stepanov AV; Charushin VN; Chupakhin ON; Kotovskaia SK; Rusinov VL
Eksp Klin Farmakol; 2015; 78(2):34-8. PubMed ID: 25898546
[TBL] [Abstract][Full Text] [Related]
73. Trazodone and omeprazole interaction causing frequent second-degree Mobitz type 1 atrioventricular (AV) block (Wenckebach phenomenon) and syncope: a case report and literature review.
Akinseye OA; Alfishawy M; Radparvar F; Bakshi S
Am J Case Rep; 2015 May; 16():319-21. PubMed ID: 26017199
[TBL] [Abstract][Full Text] [Related]
74. Rhabdomyolysis precipitated by possible interaction of ticagrelor with high-dose atorvastatin.
Kido K; Wheeler MB; Seratnahaei A; Bailey A; Bain JA
J Am Pharm Assoc (2003); 2015; 55(3):320-3. PubMed ID: 26003161
[TBL] [Abstract][Full Text] [Related]
75. Population pharmacokinetics of levofloxacin in Korean patients.
Kiem S; Ryu SM; Lee YM; Schentag JJ; Kim YW; Kim HK; Jang HJ; Joo YD; Jin K; Shin JG; Ghim JL
J Chemother; 2016 Aug; 28(4):308-13. PubMed ID: 25976699
[TBL] [Abstract][Full Text] [Related]
76. Clinical relevance of clopidogrel-proton pump inhibitors interaction.
Bouziana SD; Tziomalos K
World J Gastrointest Pharmacol Ther; 2015 May; 6(2):17-21. PubMed ID: 25949846
[TBL] [Abstract][Full Text] [Related]
77. [Liver damage caused by atorvastatin and cyclosporine in patients with renal transplant].
Ivandić E; Bašić-Jukić N
Acta Med Croatica; 2014 Apr; 68(2):175-8. PubMed ID: 26012156
[TBL] [Abstract][Full Text] [Related]
78. Molecular mechanism of statin-mediated LOX-1 inhibition.
Biocca S; Iacovelli F; Matarazzo S; Vindigni G; Oteri F; Desideri A; Falconi M
Cell Cycle; 2015; 14(10):1583-95. PubMed ID: 25950192
[TBL] [Abstract][Full Text] [Related]
79. Drug-drug interactions that interfere with statin metabolism.
Hirota T; Ieiri I
Expert Opin Drug Metab Toxicol; 2015; 11(9):1435-47. PubMed ID: 26058399
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
